CASTLE BIOSCIENCES INC
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
Castle Biosciences develops and provides genomic diagnostic tests used to assess risk in cancers such as melanoma and other skin cancers, as well as certain other conditions, helping physicians guide treatment decisions based on a patient's individual disease biology.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Juvenal Tobin WChief Commercial Officer | Sell | $111K | 3,288at $33.64 | Oct 12, 2026 |
| MAETZOLD DEREK JPres. & Chief Exec. Officer | Sell | $305K | 8,580at $35.57 | Oct 5, 2026 |
| MAETZOLD DEREK JPres. & Chief Exec. Officer | Sell | $114K | 3,198at $35.57 | Oct 5, 2026 |
| MAETZOLD DEREK JPres. & Chief Exec. Officer | Sell | $97K | 2,718at $35.57 | Oct 5, 2026 |
| Oelschlager Kristen MChief Operating Officer | Sell | $100K | 2,807at $35.75 | Oct 1, 2026 |
| Oelschlager Kristen MChief Operating Officer | Sell | $49K | 1,346at $36.38 | Oct 1, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CSTL activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.